Saurabh Zanwar MD

PubMed

• Venetoclax-based treatment combinations in relapsed/refractory multiple myeloma: practice patterns and impact of secondary cytogenetic abnormalities on outcomes.
  Abiola Bolarinwa, Madhu Nagaraj, Saurabh Zanwar, Nadine Abdallah, P Leif Bergsagel
  Blood Cancer Journal. 2025-04-04
• 1 citations
  Risk-adapted treatment for multiple myeloma: assessing the current potential and a roadmap for the future.
  Saurabh Zanwar, Shaji Kumar
  Leukemia & Lymphoma. 2025-04-01
• Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variants.
  Aldo A Acosta-Medina, Jithma P Abeykoon, Saurabh Zanwar, Gordon J Ruan, Karen L Rech
  Leukemia. 2025-04-01

Journal Articles

• Primary Systemic Amyloidosis in Patients with Waldenström Macroglobulinemia  
  Angela Dispenzieri, Eli Muchtar, Ronald Go, Saurabh Zanwar, Surbhi Sidana, Francis Buadi, Stephen M Ansell, Prashant Kapoor, David Dingli, Thomas Habermann, Shaji Kuma..., Nature
• Daratumumab-Based Therapy in Patients with Heavily-Pretreated AL Amyloidosis  
  Saurabh Zanwar, Angela Dispenzieri, Wilson Gonsalves, David Dingli, Jithma P Abeykoon, Martha Q Lacy, Shaji Kumar, Nelson Leung, Morie A Gertz, Eli Muchtar, Francis Bu..., Nature

Lectures

• Rituximab-based maintenance therapy in Waldenström macroglobulinemia: A case control study. 
  2019 ASCO Annual Meeting - 6/1/2019
• Predictors of disease progression in smoldering Waldenstram macroglobulinemia. 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018